Table 14.
Group | Dose (mg/cm2/d) |
Skin Blackening Time (Day) | Newborn Hair Growth Rating | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Day 7 | Day 14 | Day 21 | |||||||||||||||
I | II | III | IV | p | I | II | III | IV | p | I | II | III | IV | p | |||
Model control group | — | 11.70 ± 3.64 | 8 | 2 | 0 | 0 | — | 1 | 1 | 4 | 4 | — | 0 | 1 | 2 | 7 | — |
Minoxidi control group | 0.500 | 8.70 ± 1.70 * | 0 | 9 | 1 | 0 | p ≤ 0.01 | 0 | 0 | 0 | 10 | p ≤ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
β-sitosterol group 2 | 0.061 | 8.80 ± 2.04 * | 3 | 5 | 2 | 0 | p ≤ 0.01 | 0 | 0 | 1 | 9 | p ≤ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
β-sitosterol group 3 | 0.031 | 9.10 ± 1.73 | 2 | 8 | 0 | 0 | p ≤ 0.01 | 0 | 0 | 2 | 8 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
β-sitosterol group 4 | 0.016 | 8.80 ± 1.03 * | 1 | 8 | 1 | 0 | p ≤ 0.01 | 0 | 0 | 1 | 9 | p ≤ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
linoleic acid group 1 | 0.313 | 9.10 ± 1.52 | 3 | 6 | 1 | 0 | p ≤ 0.01 | 0 | 0 | 2 | 8 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
linoleic acid group 2 | 0.156 | 8.70 ± 0.82 * | 2 | 8 | 0 | 0 | p ≤ 0.01 | 0 | 0 | 1 | 9 | p ≤ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
linoleic acid group 3 | 0.078 | 9.10 ± 1.29 | 2 | 7 | 1 | 0 | p ≤ 0.01 | 0 | 1 | 3 | 6 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
vitamin E group 1 | 0.313 | 10.20 ± 2.62 | 3 | 7 | 0 | 0 | p ≤ 0.01 | 0 | 2 | 1 | 7 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
vitamin E group 2 | 0.156 | 8.50 ± 1.18 * | 2 | 7 | 1 | 0 | p ≤ 0.01 | 0 | 0 | 1 | 9 | p ≤ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
vitamin E group 3 | 0.078 | 9.10 ± 1.79 | 3 | 7 | 0 | 0 | p ≤ 0.01 | 0 | 1 | 1 | 8 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Fucosterol group 2 | 0.061 | 9.10 ± 1.10 * | 1 | 9 | 0 | 0 | p ≤ 0.01 | 0 | 1 | 3 | 6 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Fucosterol group 3 | 0.031 | 10.20 ± 2.62 | 5 | 5 | 0 | 0 | p ≥ 0.05 | 1 | 0 | 4 | 5 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Fucosterol group 4 | 0.016 | 9.20 ± 2.49 | 2 | 7 | 1 | 0 | p ≤ 0.01 | 0 | 1 | 2 | 7 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Amygdalin group 2 | 0.061 | 9.70 ± 1.83 | 0 | 10 | 0 | 0 | p ≤ 0.01 | 0 | 0 | 2 | 8 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Amygdalin group 3 | 0.031 | 9.40 ± 1.43 | 3 | 7 | 0 | 0 | p ≤ 0.01 | 0 | 1 | 2 | 7 | p ≥ 0.05 | 0 | 0 | 1 | 9 | p ≥ 0.05 |
Amygdalin group 4 | 0.016 | 9.20 ± 0.92 | 2 | 7 | 1 | 0 | p ≤ 0.01 | 0 | 1 | 4 | 5 | p ≥ 0.05 | 0 | 0 | 0 | 10 | p ≥ 0.05 |
Note: Compared with the model control group, * p ≤ 0.05, ** p ≤ 0.01.